Evio(OTC) EVIO

EVIO, Inc. is a specialized analytical testing and advisory services provider for the cannabis industry across the United States. The company offers a comprehensive range of laboratory analyses and consulting services, ensuring compliance with regulatory standards.

Products and Services

• Analytical testing for cannabinoid potency and terpene profiling
• Consulting services for product formulation and regulatory compliance
• Laboratory analyses including pesticide screening and biological contaminant testing

Growth Outlook

• Revenue of $615,000 reported in the most recent quarter
• Gross profit margin improved to 41.6% in Q1 2023
• Strategic positioning in the growing cannabis market enhances future opportunities

Financial Highlights

• Net income of $51,000 in Q1 2023, a significant turnaround
• Trailing twelve months (TTM) P/E ratio of 1.67 indicates potential value
• Operating cash flow of $444,000 in Q1 2023 demonstrates operational efficiency

EVIO, Inc. operates in the rapidly expanding cannabis sector, providing essential services that support compliance and product quality. The recent financial performance indicates a positive trend, with a notable increase in revenue and gross profit margins. The company's strategic focus on analytical testing and consulting positions it well to capitalize on the growing demand for cannabis-related services. With a low P/E ratio, EVIO may present an attractive opportunity for investors looking to enter the cannabis industry. The operational cash flow reflects a commitment to improving financial health, suggesting a potential for sustainable growth in the future.